BIO-TECHNE CORPORATION (TECH) 8-K Summary

This 8-K, filed Oct 30, 2025, announces material events occurring around the Annual Meeting and upcoming financial disclosure.

Key Investor Takeaways:

• Financial Reporting: Q3 2025 results are detailed in a press release dated November 5, 2025 (Item 2.02).
• Shareholder Actions (Annual Meeting):
  • Quorum achieved with ~90.45% shareholder participation.
  • All 9 director nominees were elected with strong support.
  • Executive Compensation plan (Say-on-Pay) was approved, though received notable opposition: